Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence-Reference-Cited by-同舟云学术

Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence

Published:2011-04-19 Issue:sup2 Volume:52 Page:75-78
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Else Monica,Dearden Claire E.,Matutes Estella,Forconi Francesco,Lauria Francesco,Ahmad Humayun,Kelly Susan,Liyanage Anandika,Ratnayake Vijitha,Shankari Jagadeesan,Whalley Ioana,Catovsky Daniel

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.568650

Reference12 articles.

1. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

2. Deoxycoformycin in the treatment of patients with hairy cell leukemia

3. Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

4. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

5. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It’s time to change the standard of care for hairy cell leukemia?!;Leukemia & Lymphoma;2024-07-05

2. Hairy cell leukemia 2024: Update on diagnosis, risk‐stratification, and treatment—Annual updates in hematological malignancies;American Journal of Hematology;2024-03-05

3. Hairy cell leukemia with isolated bone lesions;Clinical Case Reports;2023-05

4. Long-term follow-up of patients with hairy cell leukemia in the south of Iran;Expert Review of Hematology;2023-02-12

5. Cultivation, Bioactive Metabolites, and Application of Caterpillar Mushroom Cordyceps militaris: Current State, Issues, and Perspectives;Fungi and Fungal Products in Human Welfare and Biotechnology;2023